Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal Article
RECOVERY Collaborative Group, . (2021)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397(10274), 605-612. https://doi.org/10.1016/S0140-6736%2821%2900149-5
Background:
Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromy...
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Journal Article
Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., …Oxford COVID Vaccine Trial Group, . (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet, 397(10269), 99-111. https://doi.org/10.1016/S0140-6736%2820%2932661-1
Background
A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control...
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Journal Article
The RECOVERY Collaborative Group, . (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine, 383, 2030-2040. https://doi.org/10.1056/NEJMoa2022926
Background
Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontro...
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal Article
RECOVERY Collaborative Group, . (2020)
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 396(10259), 1345-1352. https://doi.org/10.1016/s0140-6736%2820%2932013-4
Background:
Lopinavir-ritonavir has been proposed as a treatment for COVID-19 on the basis of in vitro activity, preclinical studies, and observational studies. Here, we repo...
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report
Journal Article
The RECOVERY Collaborative Group, . (2021)
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. New England Journal of Medicine, 384, 693-704. https://doi.org/10.1056/NEJMoa2021436
BACKGROUND
Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progre...
The Scottish Approach: A case study of the Out-Of-Hospital Cardiac Arrest Strategy
Report
Lloyd, A. (2017)
The Scottish Approach: A case study of the Out-Of-Hospital Cardiac Arrest Strategy. The Scottish Government
This report sets out the findings from a series of interviews with partner organisations involved in the design and delivery of Scotland’s first national Out-of-Hospital Cardi...
How to implement live video recording in the clinical environment: A practical guide for clinical services
Journal Article
Lloyd, A., Dewar, A., Edgar, S., Caesar, D., Gowens, P., & Clegg, G. (2017)
How to implement live video recording in the clinical environment: A practical guide for clinical services. International Journal of Clinical Practice, 71(6), https://doi.org/10.1111/ijcp.12951
Background: The use of video in healthcare is becoming more common, particularly in simulation and educational settings. However, video recording live episodes of clinical car...